These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7188136)
1. Observations with Mydocalm in angiological practice. Balogh A Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136 [No Abstract] [Full Text] [Related]
2. Observations with intensive Mydocalm treatment in neurological cases. Perényi G Ther Hung; 1987; 35(2):66-70. PubMed ID: 3326207 [No Abstract] [Full Text] [Related]
3. Observations with higher Mydocalm doses in outpatients of the surgical department. Huber L Ther Hung; 1986; 34(4):243-7. PubMed ID: 3449980 [No Abstract] [Full Text] [Related]
4. High-dose Mydocalm therapy in certain myogenous headaches. Csányi L Ther Hung; 1989; 37(2):115-8. PubMed ID: 2686081 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant effect of oral Mydocalm treatment with massive doses in locomotor disease patients. Konrád K Ther Hung; 1987; 35(3):152-5. PubMed ID: 3438877 [No Abstract] [Full Text] [Related]
6. Mydocalm (Tolperison) in the treatment of myogenic dorsal pain. Ammer K Ther Hung; 1980; 28(2):67-9. PubMed ID: 6451044 [No Abstract] [Full Text] [Related]
7. Combined drug treatment of neurological inflammatory processes. Perényi G Ther Hung; 1981; 29(4):186-90. PubMed ID: 7188145 [No Abstract] [Full Text] [Related]
8. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis. Dömötör E Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773 [No Abstract] [Full Text] [Related]
10. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities. Fényes G; Gótzy G; Fehrentheil L Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705 [No Abstract] [Full Text] [Related]
11. Several years observations with Mydocalm muscle relaxant in locomotor disease patients. Gálos G Ther Hung; 1992; 40(2):69-71. PubMed ID: 1462278 [TBL] [Abstract][Full Text] [Related]
12. Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin. Abrányi I Ther Hung; 1988; 36(2):56-61. PubMed ID: 3201387 [No Abstract] [Full Text] [Related]
13. [Clinical use of "Muscarum" in temporomandibular joint syndrome]. Shirakawa M; Uzawa S; Shizume M; Wade H; Nakajima T Shikai Tenbo; 1979; 53(3):517-20. PubMed ID: 295974 [No Abstract] [Full Text] [Related]
14. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES]. LINKE H Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726 [No Abstract] [Full Text] [Related]
16. Experiences with the combined use of Mydocalm + Donalgin in the treatment of patients suffering from lumboischialgia. Kumin M; Saál M; Ambrózy G Ther Hung; 1984; 32(1):26-8. PubMed ID: 6242725 [No Abstract] [Full Text] [Related]
17. [Combined use of pharmacological preparations and a method of functional biocontrol in children with spastic forms of infantile cerebral palsy]. Shaĭtor VM; Bogdanov OV Pediatriia; 1988; (2):111-2. PubMed ID: 3375017 [No Abstract] [Full Text] [Related]
19. Successful use of mydocalm in peripheral arterial disease. MOLNAR L Ther Hung; 1962; 10():10-2. PubMed ID: 13935926 [No Abstract] [Full Text] [Related]
20. [Treatment of neurosensory hypoacusis of antibiotic and non-antibiotic etiology with mydocalm and nootropil: comparison of efficacy]. Alibekov IM Vestn Otorinolaringol; 1997; (4):20-3. PubMed ID: 9334010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]